Current topics in neurotoxicity the adenosinergic system

Rubriek: Textual/Printed/Reference Materials - Boek

Prijs: 173.99 Nu voor: € 155

Rating: 0/5

☆

☆

☆

☆

☆

Verzending:
Uiterlijk 29 oktober in huis

Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease and alleviation of symptoms. This book addresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinson's Disease, (2) an overview of neuroimaging studies in human health and disease, and (3) a study of urate as a possible biomarker and neuroprotectant.

Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease and alleviation of symptoms. This book addresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinson's Disease, (2) an overview of neuroimaging studies in human death and disease and (3) a study of urate as a possible biomarker and neuroprotectant.

• 1 Bekijk alle specificaties

Taal: en

Bindwijze: Paperback

Oorspronkelijke releasedatum: 22 oktober 2016

Aantal pagina's: 337

Illustraties: Nee

Hoofdredacteur: Micaela Morelli

Tweede Redacteur: Nicola Simola

Co Redacteur: Jadwiga Wardas

Hoofduitgeverij: Springer International Publishing Ag

Editie: 1

Extra groot lettertype: Nee

Product breedte: 155 mm

Product lengte: 235 mm

Studieboek: Ja

Verpakking breedte: 155 mm

Verpakking hoogte: 19 mm

Verpakking lengte: 235 mm

Verpakkingsgewicht: 5329 g

EAN: 9783319371863

---